AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 191 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 3.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,764,000 | +16.7% | 80,000 | +6.7% | 1.58% | +10.7% |
| Q1 2018 | $1,511,000 | +153.5% | 75,000 | +66.7% | 1.43% | +130.9% |
| Q4 2017 | $596,000 | +115.2% | 45,000 | +200.0% | 0.62% | +102.3% |
| Q3 2017 | $277,000 | +0.4% | 15,000 | 0.0% | 0.31% | -16.6% |
| Q2 2017 | $276,000 | -4.5% | 15,000 | +17.1% | 0.37% | +18.4% |
| Q1 2017 | $289,000 | -88.6% | 12,813 | -82.4% | 0.31% | -90.4% |
| Q4 2016 | $2,534,000 | -5.8% | 72,813 | -33.7% | 3.24% | +14.1% |
| Q3 2016 | $2,691,000 | +277.4% | 109,813 | +268.3% | 2.84% | +181.9% |
| Q2 2016 | $713,000 | -23.5% | 29,813 | -25.1% | 1.01% | +49.7% |
| Q1 2016 | $932,000 | +196.8% | 39,813 | +282.8% | 0.67% | +223.1% |
| Q4 2015 | $314,000 | -24.0% | 10,400 | 0.0% | 0.21% | -24.9% |
| Q3 2015 | $413,000 | – | 10,400 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 520,000 | $15,699,000 | 7.39% |
| Palo Alto Investors LP | 2,835,792 | $85,613,000 | 4.76% |
| Opaleye Management Inc. | 150,000 | $4,529,000 | 1.89% |
| Engaged Capital LLC | 61,425 | $1,854,000 | 1.15% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 91,400 | $2,759,000 | 1.14% |
| Endurant Capital Management LP | 111,180 | $3,357,000 | 1.12% |
| AlphaOne Investment Services, LLC | 86,817 | $2,621,000 | 0.94% |
| ASHFORD CAPITAL MANAGEMENT INC | 127,625 | $3,853,000 | 0.91% |
| ARDSLEY ADVISORY PARTNERS LP | 205,000 | $6,189,000 | 0.81% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 685,000 | $20,680,000 | 0.62% |